Last reviewed · How we verify
NCT04694287: VOLAII
Volume Flow Assessment to Optimize Angioplasty of Dysfunctional Dialysis Access
trial testing Percutaneous DUS volume flow measurements in Dialysis Access Malfunction in 100 participants. Completed in 15 February 2023.
15 February 2023
Quick facts
| Lead sponsor | Attikon Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 June 2020 |
| Primary completion | 15 February 2023 |
| Estimated completion | 15 February 2023 |
| Sites | 3 locations across Greece |
Drugs / interventions tested
- Percutaneous DUS volume flow measurements
Conditions studied
- Dialysis Access Malfunction — all drugs for Dialysis Access Malfunction →
Sponsor
Attikon Hospital
Who can join
Adults 18 to 90, any sex, with Dialysis Access Malfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multicenter, prospective study investigating a new concept of intra-procedural percutaneous duplex ultrasound (DUS) volume flow-guided balloon angioplasty for the quantification and optimization of endovascular treatment outcomes of dysfunctional autologous arteriovenous fistulae (AVF).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
US Volume Flow Assessment to Optimize Angioplasty of Dysfunctional Dialysis Access: The VOLA-II Multicenter Study.
Spiliopoulos S, Filippou P, Giannikouris IE, Katsanos K, et al · · 2024 · cited 1× · PMID 39589250 · DOI 10.1148/radiol.233076
Verify or expand the search:
- PubMed search for NCT04694287
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dialysis Access Malfunction
Currently open trials in the same condition.
- NCT06553443 — Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis · Phase 3 · recruiting
Other Attikon Hospital trials
Trials by the same sponsor.
- NCT07425457 — Cryoneurolysis Prior to Total Knee Arthroplasty (CRYO-TKA Trial) · NA · recruiting
- NCT06646107 — Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There · recruiting
- NCT06810700 — The Association Between Time in Range With Markers of Endothelial and Cardiovascular Function · not yet recruiting
- NCT06978387 — The Association Between Glycemic Metrics and Cardiovascular Markers in Patients With Type 1 Diabetes. · active not recruiting
- NCT06749613 — Digestive Enzyme Formulation Intervention in IBS Patients Who Previously Clinically Responded to Mediterranean LFD · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04694287 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Attikon Hospital
- Last refreshed: 21 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04694287.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing